YCN47284

CAS No. 181147-28-4

YCN47284( —— )

Catalog No. M28786 CAS No. 181147-28-4

YCN47284 is an antimalarial compound with an IC50 of 1 μM for P. falciparum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 79 In Stock
5MG 55 In Stock
10MG 101 In Stock
25MG 181 In Stock
50MG 277 In Stock
100MG 403 In Stock
200MG 573 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YCN47284
  • Note
    Research use only, not for human use.
  • Brief Description
    YCN47284 is an antimalarial compound with an IC50 of 1 μM for P. falciparum.
  • Description
    YCN47284 is an antimalarial compound with an IC50 of 1 μM for P. falciparum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    hSMG
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    181147-28-4
  • Formula Weight
    319.19
  • Molecular Formula
    C10H16Cl2N8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N=C(NN=CC1=CC=CC(/C=N/NC(N)=N)=C1)N.[H]Cl.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ariamala Gopalsamy, et al. Identification of pyrimidine derivatives as hSMG-1 inhibitors. Bioorg Med Chem Lett. 2012 Nov 1;22(21):6636-41.
molnova catalog
related products
  • Mebendazole

    A highly effective, broad-spectrum antihelmintic by selectively inhibiting the synthesis of microtubules in parasitic worms, and by destroying extant cytoplasmic microtubes in their intestinal cells.

  • 5-(3-bromo-4,5-dihyd...

    Antileishmanial agent-2 is a 3-Br-isoxazoline-Based Inhibitors against Plasmodium falciparum (D10 and W2 strains) and Leishmania spp. (L. infantum and L. tropica) Promastigotes with IC50s of 0.035, 0.058, 3.5 and 7.5 μM.

  • MBP146-78

    MBP146-78 is a potent and selective cGMP inhibitor dependent protein kinases.